China SXT Pharmaceuticals (SXTC) Shares Outstanding (2026)
China SXT Pharmaceuticals (SXTC) posted Shares Outstanding (Entity) of $13123.0 for Q1 2026.
Analysis
China SXT Pharmaceuticals (SXTC) Shares Outstanding (2026) Analysis & Trends
China SXT Pharmaceuticals has reported Shares Outstanding (Entity) for 1 years, with the latest figure at $13123.0 in Q1 2026.
- On a quarterly basis, Shares Outstanding (Entity) changed N/A year-over-year to $13123.0 in Q1 2026; TTM through Mar 2026 was $13123.0, a N/A change from a year earlier, with the FY2026 full-year figure at $13123.0, changed N/A from the prior year.
- Shares Outstanding (Entity) was $13123.0 for Q1 2026 at China SXT Pharmaceuticals.
- The five-year high for Shares Outstanding (Entity) was $13123.0 in Q1 2026, with the low at $13123.0 in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.95 Bn | 625.20 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 441.39 Bn | 434.82 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 366.72 Bn | 359.58 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 266.68 Bn | 258.99 Bn | 11.24 Bn | 1.94 Bn |
| 5 | Pfizer | 159.20 Bn | 147.50 Bn | 10.94 Bn | 5.70 Bn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | 1.22 Bn |
| 7 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | 210.89 Mn |
| 8 | Incyte | 25.50 Bn | 20.96 Bn | 1.57 Bn | 200.38 Mn |
| 9 | United Therapeutics | 21.54 Bn | 18.88 Bn | 683.80 Mn | 42.60 Mn |
| 10 | China SXT Pharmaceuticals | 18,606.24 | -28.16 Mn | - | 8,496.00 |